ESCMID eLibrary

Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. P2699

   Prevalence, antibiotic resistance patterns and spa types of MRSA from hospitalised patients in Germany, 2010-2016

   Michael Kresken, Rheinbach, Germany

   Michael Kresken , Franziska Layer , Barbara Körber-Irrgang , Guido Werner

   16 April 2019

   Session: Methicillin-resistant Staphylococcus: spanning the globe

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Bacterial Susceptibility & Resistance

2. P1619

   Dissemination of extended-spectrum beta-lactamase genes and resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany, 2010-2016

   Michael Kresken, Rheinbach, Germany

   Michael Kresken , Yvonne Pfeifer , Jennifer Karin Bender , Barbara Körber-Irrgang , Guido Werner

   15 April 2019

   Session: Urinary pathogens: surveillance and trends

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Bacterial Susceptibility & Resistance

3. P1859

   In vitro activity of cefiderocol against Gram-negative pathogens circulating in Germany

   Michael Kresken, Rheinbach, Germany

   Michael Kresken , Eileen Berwian , Sarah Wernicke , Anna Frank , Gabriele Anlauf

   15 April 2019

   Session: Cefiderocol in vitro

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   New Antibacterial Agents & Stewardship

4. P0922

   The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem-resistant Acinetobacter baumannnii isolates in Germany, 2010-2016

   Michael Kresken, Rheinbach, Germany

   Michael Kresken , Paul Higgins , Danuta Stefanik , Julia Wille , Barbara Körber-Irrgang , Harald Seifert

   14 April 2019

   Session: Acinetobacter baumannii: formidable resistance threatening many parts of the world

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Bacterial Susceptibility & Resistance

5. P1209

   Extended-spectrum beta-lactamse-producing strains among clinical isolates of Escherichia coli and Klebsiella pneumoniae from hospitalised patients in Germany, 2012-2016

   Michael Kresken, Rheinbach, Germany

   Michael Kresken , Yvonne Pfeifer , Jennifer Karin Bender , Barbara Körber-Irrgang , Guido Werner

   14 April 2019

   Session: Beta-lactamases here, there and everywhere (One Health)

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Bacterial Susceptibility & Resistance

6. P1072

   Occurrence of carbapenemase-producing strains among Enterobacteriaceae urine isolates in three geographic areas in Germany

   Michael Kresken, Rheinbach, Germany

   M. Kresken, B. Körber-Irrgang, G. Hischebeth, A. Hoerauf, N. von Allmen, M. Hogardt, T. Wichelhaus, N. Pfennigwerth, S. Gatermann

   22 April 2018

   Session: Characterization and clinical epidemiology of carbapenem-resistant Enterobacteriaceae

   Relevance:

    

   100%

    

   

   Event: ECCMID 2018
   Madrid, Spain
   Abstract publication

   Bacterial Susceptibility & Resistance

7. O0124

   Dissemination of carbapenem-resistant, carbapenemase non-producing and carbapenemase-producing Pseudomonas aeruginosa in Germany

   Michael Kresken, Rheinbach, Germany

   M. Kresken, B. Körber-Irrgang, M. Korte-Berwanger, N. Pfennigwerth, S. Gatermann

   21 April 2018

   Session: Hot spots in Pseudomonas aeruginosa

   Relevance:

    

   100%

    

   

   Event: ECCMID 2018
   Madrid, Spain
   Abstract publication

   Bacterial Susceptibility & Resistance

8. P1201

   In vitro pharmacodynamics of ceftobiprole against Staphylococcus aureus at concentrations corresponding to free drug levels achieved in human serum

   Michael Kresken, Rheinbach, Germany

   Michael Kresken, Barbara Körber-Irrgang

   24 April 2017

   Session: PK/PD in preclinical models

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Poster presentation

   New Antibacterial Agents & Stewardship

9. P1235

   In vitro activity of ceftolozane-tazobactam against Pseudomonas aeruginosa isolates non-susceptible to ceftazidime or meropenem

   Michael Kresken, Rheinbach, Germany

   Michael Kresken, Barbara Körber-Irrgang, Harald Seifert

   24 April 2017

   Session: Focus Pseudomonas aeruginosa and novel agents against non-fermenters

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Poster presentation

   Bacterial Susceptibility & Resistance

10. ASC024

    PEG - Paul-Ehrlich-Gesellschaft für Chemotherapie e. V.

    Michael Kresken, Rheinbach, Germany

    22 April 2017

    Session: Affiliated Societies Corner 2017

    Relevance:

     

    100%

     

    

    Event: ECCMID 2017
    Vienna, Austria
    ePoster presentation

    Other